Infertility. Female infertility
Conditions
Interventions
Intervention 1: transvaginal injection of GCSF 300 IU, single dose, 2 or 5 days before embryo transfer. Intervention 2: prescription of OCP for 21 days plus 50 mcg GNRH agonist single dose on the 3rd
Treatment - Drugs
Placebo
transvaginal injection of GCSF 300 IU, single dose, 2 or 5 days before embryo transfer.
prescription of OCP for 21 days plus 50 mcg GNRH agonist single dose on the 3rd day of menstrual period and 300 to 450 IU FSH or HMG, single dose, on the 14th day of menstrual period.
Sponsors
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: (a) Infertile; (b) age of 20 to 40 years; (c) having determined factor such as endometriosis, myoma, or Asherman's syndrome. Exclusion criteria: (a) having cycle cell anemia, renal failure, upper or lower respiratory infection, or malignancy; (b) contraindication for pregnancy; (c) weak response rate.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnosis of gestational sac and observation of embryo. Timepoint: 24 days after embryo transfer. Method of measurement: by transvaginal ultrasonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Zahra yazdi
Fatemieh Hospital
Outcome results
None listed